Candel Therapeutics
Price & Volume
Stats
See more52W Range | $4.35-$11.35 |
Market Cap | $769.3M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$23M |
Diluted EPS | -$1 |
News
See moreYahoo Finance • last month
Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Candel Therapeutics Designates Mark Sims as CCO
Yahoo Finance • 2 months ago
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
Candel Therapeutics GAAP EPS of -$0.14 beats by $0.19
About
CEO | Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. |
CFO | Mr. Charles Schoch |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |